Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine monocyte chemoattractant protein-1 by human astrocytes

被引:53
作者
Ge, SJ [1 ]
Pachter, JS [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Pharmacol, Blood Brain Barrier Lab, Farmington, CT 06030 USA
关键词
D O I
10.1074/jbc.M311769200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Astrocytes regulate the integrity of the blood-brain barrier and influence inflammatory processes in the central nervous system. The pro-inflammatory chemokine monocyte chemoattractant protein-1 (MCP-1), which is both released by and stimulates astrocytes, is thought to play a crucial role in both these activities. Because astrocytes have been shown to possess caveolae, vesicular structures that participate in intracellular transport and signal transduction events, we reasoned that expression of the major structural protein of these organelles, caveolin-1, might feature critically in the cellular responses to MCP-1. To test this hypothesis, caveolin-1 level was "knocked down" in human astrocyte cultures by using a small interfering RNA approach. This method resulted in efficient (>90% loss) and specific knockdown of caveolin-1 expression while sparring glial fibrillary acidic protein as well as several other proteins involved in endocytosis. Astrocytes suffering caveolin-1 loss showed diminished ability to down-modulate and internalize the MCP-1 receptor (CCR2) in response to exposure to this chemokine and also demonstrated significantly reduced capacity to undergo chemotaxis and calcium flux when MCP-1-stimulated. The results highlight a potentially prominent role for caveolae and/or caveolin-1 in mediating astrocyte responses to MCP-1, a feature that might significantly dictate the progression of inflammatory events at the blood-brain barrier.
引用
收藏
页码:6688 / 6695
页数:8
相关论文
共 67 条
[1]  
Andjelkovic AV, 1999, GLIA, V28, P225, DOI 10.1002/(SICI)1098-1136(199912)28:3<225::AID-GLIA6>3.3.CO
[2]  
2-Y
[3]   Functional expression of CCR2 by human fetal astrocytes [J].
Andjelkovic, AV ;
Song, L ;
Dzenko, KA ;
Cong, H ;
Pachter, JS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (02) :219-231
[4]  
Andjelkovic AV, 2000, J LEUKOCYTE BIOL, V68, P545
[5]  
ANDJELKOVIC AV, 2002, UNIVERSES DELICATE B, P301
[6]   Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor [J].
Aramori, I ;
Zhang, J ;
Ferguson, SSG ;
Bieniasz, PD ;
Cullen, BR ;
Caron, MG .
EMBO JOURNAL, 1997, 16 (15) :4606-4616
[7]   Characterization of chemokines and their receptors in the central nervous system: physiopathological implications [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1311-1329
[8]   Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain [J].
Banisadr, G ;
Quéraud-Lesaux, F ;
Boutterin, MC ;
Pélaprat, D ;
Zalc, B ;
Rostène, W ;
Haour, F ;
Parsadaniantz, SM .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) :257-269
[9]  
Berman JW, 1996, J IMMUNOL, V156, P3017
[10]   Chemokines in the brain: neuroimmunology and beyond [J].
Biber, K ;
Zuurman, MW ;
Dijkstra, IM ;
Boddeke, HWGM .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (01) :63-68